ANI Pharmaceuticals (NASDAQ:ANIP) announced that following final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application, the company launched Estradiol Gel, 0.06% ...

PRINCETON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- (ANI or the Company) (Nasdaq: ANIP) today announced that following final ...

Elestrin™ is a new gel formulation of estradiol that benefits from the technological advantages of transdermal administration. By virtue of its sustained release, Elestrin may be applied once daily.

In certain age groups, pellets or bioidentical hormone implants are a frequent topic of conversation over coffee or during ...

CBT for menopause is one of the recommended alternatives to HRT. Here's what happened when writer Laura Williams was ...

Study identifies key inflammatory and immune response proteins linked to endometrial cancer risk through both observational and Mendelian Randomization analyses, revealing the roles of IL-6 and ...

Provides Daré access to capital at Daré’s discretion with any proceeds available to help fund portfolio advancement, such as ...

ARPA-H sought solutions within six topics of interest in women's health, and received an unprecedented response of submissions. ARPA-H launched the Sprint for Women's Health in February, with First ...

Peak Energy CEO, Gavin Adda speaking at Keynote Session: Strategic Entry and Expansion: Unlocking Asia's Solar and Storage ...

ANI Pharmaceuticals (ANIP) announced that following final approval from the U.S. FDA for its Abbreviated New Drug Application, the company ...

Therapy with Elestrin fits all these points and it is therefore reasonable to suggest that the employment of estradiol gel in general and of Elestrin specifically, is destined to increase in the ...